Document is current
Any future updates will be listed below
-
Authors
Carpten, John D.
Fashoyin-Aje, Lola
Garraway, Levi A.
Winn, Robert
- License Information
-
More Information
Article History
Accepted: 13 May 2021
First Online: 29 June 2021
Competing interests
: J.D.C. receives honoraria as a current member of the external advisory council for the Genentech (Roche) Advancing Inclusive Research Program, receives honoraria as a current member of the scientific advisory board for Break Through Cancer, receives honoraria as a current member of the scientific advisory council for Stand Up To Cancer, is a current member of the board of directors of the American Association of Cancer Research and is a current member of the board of directors of Tower Cancer Research Foundation. L.A.G. is an employee and shareholder of Roche and is an equity holder of Tango Therapeutics. L.F.-A. and R.W. declare no competing interests.
